Business & Investment

Walgreens maintains its full-year profit growth forecast.Stock price rise due to Reuters

2/2
© Reuters.There is a sign at the Walgreens Pharmacy counter in Austin, Texas

2/2

By Mrinalika Roy and Dania Nadeem

(Reuters)-Walgreens Boots Alliance (NASDAQ :) Inc said Thursday, hoping to benefit from COVID-19 vaccination to mitigate the effects of pandemic regulation, sticking to full-year earnings growth forecasts and increasing market share by 7% It was. ..

The drug store chain profits after the health crisis hit sales, cut jobs, closed UK-based boot stores and sold its distribution unit to AmerisourceBergen (NYSE :) Corp for $ 6.5 billion. We have taken some steps to increase the number of people.

Rivals CVS Health Corp (NYSE :) and Walgreens have agreed with the federal government to vaccinate nursing home residents across the United States through a voluntary program.

Walgreens said it expects to benefit from COVID-19 vaccination in the second half of fiscal year 2021.

“Vaccination of long-term care facilities is not a particularly profitable business,” said Stefano Pessina, chief executive officer.

“That said, the vaccine will be added to the profile later this year, and that’s why … we changed the tone of the guidance.”

Walgreens maintained its 2021 forecast of low single-digit growth in adjusted EPS after surpassing analysts’ estimates of adjusted first-quarter profits.

Boots UK pharmacy same-store sales grew 2.5% this quarter, while Boots.com sales grew 106%.

Walgreens expects its UK operations to grow significantly in the second half of this year due to cost savings. But the company warned that the blockade in the UK could have a negative impact on its business.

“It’s a big negative and big question mark, and we basically keep the guidance because it’s blocked in the UK until mid-February,” said Chief Financial Officer James Keeho.

Disclaimer: Fusion media We inform you that the data contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indexes, futures) and forex prices are provided by the market maker, not the exchange, so prices may not be accurate and may differ from actual market prices. In other words, price is an indicator and is not suitable for trading purposes. Therefore, Fusion Media is not responsible for any transactional losses that may occur as a result of using this data.

Fusion media Alternatively, anyone involved with Fusion Media will not be liable for any loss or damage resulting from relying on the data, quotes, charts, trading signals and other information contained on this website. Please be fully informed about the risks and costs associated with trading in financial markets. This is one of the most risky forms of investment possible.



Walgreens maintains its full-year profit growth forecast.Stock price rise due to Reuters

https://www.investing.com/news/stock-market-news/walgreens-posts-loss-on-15-billion-charge-2381780 Walgreens maintains its full-year profit growth forecast.Stock price rise due to Reuters

Back to top button